JPWO2021049671A1 - - Google Patents

Info

Publication number
JPWO2021049671A1
JPWO2021049671A1 JP2021545654A JP2021545654A JPWO2021049671A1 JP WO2021049671 A1 JPWO2021049671 A1 JP WO2021049671A1 JP 2021545654 A JP2021545654 A JP 2021545654A JP 2021545654 A JP2021545654 A JP 2021545654A JP WO2021049671 A1 JPWO2021049671 A1 JP WO2021049671A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021545654A
Other languages
Japanese (ja)
Other versions
JP7660898B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021049671A1 publication Critical patent/JPWO2021049671A1/ja
Priority to JP2025052355A priority Critical patent/JP2025098184A/ja
Application granted granted Critical
Publication of JP7660898B2 publication Critical patent/JP7660898B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2021545654A 2019-09-09 2020-09-08 マイクロrnaを含む体液抽出物 Active JP7660898B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025052355A JP2025098184A (ja) 2019-09-09 2025-03-26 マイクロrnaを含む体液抽出物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019193847 2019-09-09
JP2019193847 2019-09-09
PCT/JP2020/037487 WO2021049671A1 (ja) 2019-09-09 2020-09-08 マイクロrnaを含む体液抽出物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025052355A Division JP2025098184A (ja) 2019-09-09 2025-03-26 マイクロrnaを含む体液抽出物

Publications (2)

Publication Number Publication Date
JPWO2021049671A1 true JPWO2021049671A1 (https=) 2021-03-18
JP7660898B2 JP7660898B2 (ja) 2025-04-14

Family

ID=74865791

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021545654A Active JP7660898B2 (ja) 2019-09-09 2020-09-08 マイクロrnaを含む体液抽出物
JP2025052355A Pending JP2025098184A (ja) 2019-09-09 2025-03-26 マイクロrnaを含む体液抽出物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025052355A Pending JP2025098184A (ja) 2019-09-09 2025-03-26 マイクロrnaを含む体液抽出物

Country Status (5)

Country Link
US (1) US20230265521A1 (https=)
EP (1) EP4029940A4 (https=)
JP (2) JP7660898B2 (https=)
CN (1) CN115038796A (https=)
WO (1) WO2021049671A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114540491A (zh) * 2021-12-08 2022-05-27 北京尧景基因技术有限公司 一种基于岩藻糖基化细胞外囊泡中差异化表达miRNA的肝癌预测模型建立及应用

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110799648B (zh) * 2017-06-29 2024-03-22 东丽株式会社 用于检测肺癌的试剂盒、装置和方法
CN113134010B (zh) * 2020-01-20 2023-09-01 上海市生物医药技术研究院 一种靶向雌激素受体α的微小RNA及其抗肿瘤用途
CN111534598B (zh) * 2020-06-11 2023-05-02 广西医科大学第一附属医院 与结直肠癌患者肿瘤突变负荷水平相关的miRNA标志物及应用
EP4211273B1 (en) * 2020-09-14 2025-10-29 Institut National de la Santé et de la Recherche Médicale Method to treat and stratificate a patient suffering from a cancer
EP4314321A4 (en) * 2021-03-24 2025-06-04 Craif Inc. MIARN, COMPOSITIONS AND METHODS OF USE THEREOF
CN113249488A (zh) * 2021-06-29 2021-08-13 中国人民解放军空军军医大学 基于外泌体miRNA-4433-5p表达水平的胃癌恶液质早期诊断试剂盒
CN115198014A (zh) * 2021-12-03 2022-10-18 武汉博越致和生物科技有限公司 一种用于胰腺癌早期诊断的外泌体miRNA标志物组合及检测试剂盒
CN114672560B (zh) * 2022-01-12 2025-09-26 北京艾克伦医疗科技有限公司 通过外泌体miRNA标志物鉴定结直肠癌状态的检测试剂盒和方法
CN115141882A (zh) * 2022-02-23 2022-10-04 南方医科大学南方医院 黄韧带肥厚早期诊断用miRNA生物标志物、试剂盒及应用
JP2025506080A (ja) * 2022-03-09 2025-03-07 Craif株式会社 疾患アウトカムを分類する方法
CN114686586B (zh) * 2022-05-05 2023-10-20 首都医科大学附属北京胸科医院 一种用于诊断结核性胸膜炎的分子标志物组合物及其应用
CN114686593B (zh) * 2022-05-30 2022-10-25 深圳市慢性病防治中心(深圳市皮肤病防治研究所、深圳市肺部疾病防治研究所) 与乳腺癌有关的外泌体SmallRNA及其应用
CA3254846A1 (en) * 2022-06-10 2023-12-14 City Of Hope Biomarkers in pancreatic cancer
CN114959014B (zh) * 2022-06-17 2023-03-31 中山大学附属第一医院 血清miRNAs作为绝经后骨质疏松联合诊断标志物的应用
US20250382673A1 (en) * 2022-07-01 2025-12-18 City Of Hope Biomarkers in colorectal cancer
CN117802232B (zh) * 2022-09-30 2025-08-19 上海思路迪生物医学科技有限公司 血液小型胞外囊泡miRNA在卵巢癌诊断中的应用
CN117802235B (zh) * 2022-09-30 2025-08-19 上海思路迪生物医学科技有限公司 血液胞外囊泡miRNA在卵巢癌诊断中的应用
CN116024330B (zh) * 2022-12-07 2023-12-01 中国医学科学院北京协和医院 miR-137-3p在薄型子宫内膜中的应用
CN116121382A (zh) * 2022-12-15 2023-05-16 康德(深圳)生物技术有限公司 一种用于胰腺癌精准用药生物标志物的筛选方法及其专用标志物
CN116144777A (zh) * 2022-12-30 2023-05-23 贵州医科大学 用于癌症筛查的基于m1A相关miRNA诊断试剂、模型及制备方法
CN115896295A (zh) * 2022-12-30 2023-04-04 中国科学技术大学 辅助诊断胆囊炎或预测胆囊炎合并肝损伤的miRNA标志物
CN116144781B (zh) * 2023-03-23 2024-08-13 刘忠祥 用于检测肺腺癌的标记物、引物组以及试剂盒
CN116492464B (zh) * 2023-04-12 2025-08-19 天津医科大学总医院 TNFRSF1A抑制剂miR-3059-5p在治疗脑卒中疾病中的用途
WO2024232682A1 (ko) * 2023-05-09 2024-11-14 솔바이오 주식회사 전립선암의 진단 및 치료 타겟으로서 mir-6880-5p
CN116898868B (zh) * 2023-05-19 2024-02-06 青岛大学附属医院 MiR-1909-5p在制备治疗血管内皮细胞铁死亡和/或主动脉夹层产品中的应用
CN117530932B (zh) * 2024-01-08 2024-04-26 中国药科大学 一种抑制肿瘤生长及肺转移的人工外泌体及其应用
CN118932040A (zh) * 2024-07-22 2024-11-12 南通大学附属医院 miR-3591-5p作为先天性心脏病合并肺动脉高压诊断标志的应用及检测试剂盒
CN119144728B (zh) * 2024-11-19 2025-04-29 四川大学华西医院 原发性肝癌的MicroRNA标志物的引物、试剂盒和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018504915A (ja) * 2015-02-11 2018-02-22 エクシコン エ/エス 尿中の前立腺癌の早期発見のためのmicroRNAに基づく方法
JP2020092688A (ja) * 2018-12-12 2020-06-18 国立大学法人東海国立大学機構 マイクロrnaを含む体液抽出物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103320504A (zh) * 2013-01-28 2013-09-25 深圳市人民医院 检测排泄物中microRNAs作为肺癌、结直肠癌和膀胱癌早期诊断生物标志
JP6606786B2 (ja) * 2014-03-12 2019-11-20 国立大学法人名古屋大学 生体分子抽出用チップ、及び生体分子抽出用チップの製造方法
WO2016186987A1 (en) * 2015-05-15 2016-11-24 Trustees Of Dartmouth College Biomarker micrornas and method for determining tumor burden
US11571695B2 (en) * 2018-07-06 2023-02-07 Craif Inc. Fluidic device and method for separating biomolecules
WO2020090860A1 (ja) * 2018-10-30 2020-05-07 国立大学法人名古屋大学 miRNAの抽出方法、および、miRNAの解析方法
JPWO2020158832A1 (https=) * 2019-01-30 2020-08-06

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018504915A (ja) * 2015-02-11 2018-02-22 エクシコン エ/エス 尿中の前立腺癌の早期発見のためのmicroRNAに基づく方法
JP2020092688A (ja) * 2018-12-12 2020-06-18 国立大学法人東海国立大学機構 マイクロrnaを含む体液抽出物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YASUI, T. ET AL.: "Unveiling massive numbers of cancer-related urinary-microRNA candidates via nanowires", SCI. ADV., vol. vol.3, no.12, e1701133, JPN6020046766, 2017, ISSN: 0005399944 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114540491A (zh) * 2021-12-08 2022-05-27 北京尧景基因技术有限公司 一种基于岩藻糖基化细胞外囊泡中差异化表达miRNA的肝癌预测模型建立及应用
CN114540491B (zh) * 2021-12-08 2024-01-30 北京尧景基因技术有限公司 一种基于岩藻糖基化细胞外囊泡中差异化表达miRNA的肝癌预测模型建立及应用

Also Published As

Publication number Publication date
EP4029940A1 (en) 2022-07-20
EP4029940A4 (en) 2024-02-28
JP2025098184A (ja) 2025-07-01
CN115038796A (zh) 2022-09-09
JP7660898B2 (ja) 2025-04-14
US20230265521A1 (en) 2023-08-24
WO2021049671A1 (ja) 2021-03-18

Similar Documents

Publication Publication Date Title
JPWO2021049671A1 (https=)
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021017728A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
JPWO2020158832A1 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021017173A2 (https=)
BR112021017083A2 (https=)
BR112021018250A2 (https=)
BR112021018584A2 (https=)
BR112021017310A2 (https=)
AT524962A5 (https=)
BR112021018484A2 (https=)

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20230201

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230206

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230823

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240826

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241022

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250117

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250130

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250228

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250326

R150 Certificate of patent or registration of utility model

Ref document number: 7660898

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350